![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1449, 2004-01, pp. : 15-15
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacovigilance an imperfect art?
Reactions Weekly, Vol. 1, Iss. 1013, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Novel triple cocktail a new gold standard for initial ART?
Inpharma, Vol. 1, Iss. 1558, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacogenomics the next pharmacovigilance frontier?
Inpharma, Vol. 1, Iss. 1472, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The Internet and Drug Safety: What are the Implications for Pharmacovigilance?
By Cobert B.
Drug Safety, Vol. 20, Iss. 2, 1999-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
What do Stakeholders Think about Pharmacovigilance?
Drug Safety, Vol. 33, Iss. 8, 2010-08 ,pp. :